echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > European Radiology: long-term prognosis compared with ultrasound-guided corticosteroid injections for Morton neuroma

    European Radiology: long-term prognosis compared with ultrasound-guided corticosteroid injections for Morton neuroma

    • Last Update: 2022-10-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Morton neuroma (MN) is not a true neuroma, but a degenerative process of the nerve characterized by fibrosis
    of the outlet, perimembrane, and intimal membranes.
    33% to 54% of patients may be asymptomatic, and when symptomatic, management of MN can be divided into non-surgical and surgical
    .
    Non-surgical treatments include conservative or percutaneous interventions
    .

    A mixture of corticosteroids and anesthetics is one of
    the main injections used.
    Percutaneous injections can be
    performed blindly, i.
    e.
    according to anatomical landmarks or under the guidance of US

    .
    Compared with US-guided injections,
    blind piercing injections often cause short-term pain within 6 months with poor
    relief.

    A study published in the journal European Radiology compared blinded injections with US-guided injections for the long-term (up to 3 years) efficacy of MN to determine which approach is more appropriate in non-surgical treatment of this condition and evaluated the impact
    of other variables (patient age, size of neuroma, presence or absence of ipsilateral neuroma) on patient outcomes.

    This review was a randomized trial with evaluator-blinding in which 33 patients with MN were injected according to anatomical markers by an experienced orthopedic surgeon (blind puncture, Group 1) and 38 patients were injected by an experienced musculoskeletal radiologist under the guidance of US (Group 2).

    Patients were assessed
    using a visual analogue scale and the Manchester Foot Pain and Disability Index (MFPDI).
    The injection consists of injecting 1 ml of 2% mepevacaine and 40 mg of triamcinolone acetonide
    into each intraperitoneal cavity.
    During the first 3 months of follow-up, up to 4 injections
    are allowed.
    Follow-up by phone and/or appointment at 15 days, 1 month, 45 days, 2 months, 3 months, 6 months, and 1, 2, and 3 years
    .
    The statistical analysis used an unpaired student t-test
    .

    No differences
    were found in age or clinical measures between the first group (VAS, 8.
    5±0.
    2; MFPDI, 40.
    9±1.
    1) and the second group (VAS, 8.
    4±0.
    2; MFPDI, 39.
    8±1.
    2).
    At 3 years of follow-up, VAS improved better in group 2 (P < 0.
    05).

    At follow-up from 45 days to 2 years, MFPDI improved better in the second group (P < 0.
    05).

    At 3 years of follow-up, the second group (87%) was more satisfied with treatment than the first group (59.
    1%)
    .


    Figure Normal measurement
    of the finger nerve and Morton neuroma.
    A long-axis sagittal view shows that the normal
    common digital nerve (arrow) is divided into two digital nerves (arrowhead).

    B Short-axis coronary view showing
    the common pedophalangeal nerve (+).

    C Measurements made in the sagittal view, including sagittal (+) and back diameter (X).

    D Transverse diameter (+) measured in the minor axis coronal plane

    This study suggests that ultrasound-guided corticosteroid injections are more effective
    than blinded injections in patients with MN in the medium to long term.

    Original source:

    Fernando Ruiz Santiago,Pablo Tomás Muñoz,Antonio Jesús Láinez Ramos-Bossini,et al.
    Long-term comparison between blind and ultrasound-guided corticoid injections in Morton neuroma.
    DOI:10.
    1007/s00330-022-08932-y

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.